Recent Updates
Recently added Catalysts
ECOR Neutral Sentiment

electroCore to Announce First Quarter Financial Results on Wednesday, May 3

Wednesday, April 19, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: electroCore, Inc. will announce its first-quarter financial results for the period ended March 31, 2023, on May 3, 2023, following the market close. A conference call and webcast will be hosted by management at 4:30 PM EDT to discuss the results and address any stakeholder questions. The company specializes in non-invasive vagus nerve stimulation technology, aiming to enhance health through its medical devices and consumer products.
Price reaction · baseline $6.59 (2023-04-18 close) · hit after-hours · clean, no other ECOR news in the window
day 0 close · peak
+3.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • electroCore is preparing to report its first quarter financial results.
  • Management will engage with stakeholders through a conference call.
  • The company's focus on bioelectronic medicine indicates innovation in healthcare.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., April 19, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the first quarter ended March 31, 2023, after the close of the market on Wednesday, May 3, 2023. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions.
Wednesday, May 3, 2023, 4:30 PM EDT
Domestic: 877-269-7756
International: 201-689-7817
Conference ID: 13738144
Webcast: electroCore Earnings Webcast
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

When will electroCore report its financial results for Q1 2023?

electroCore will report its financial results on May 3, 2023.

What time is the conference call on May 3, 2023?

The conference call is scheduled for 4:30 PM EDT.

How can I access the electroCore earnings webcast?

You can access the earnings webcast on the electroCore website.

What is the focus of electroCore, Inc.?

electroCore focuses on bioelectronic medicine and wellness via nVNS technology.

What technology does electroCore use for health improvement?

electroCore utilizes non-invasive vagus nerve stimulation (nVNS) technology.

ShareAdd on Google
Tags: ECOR Viatris Investor Conferences Healthcare electroCore bioelectronic medicine financial results nVNS technology quarterly earnings
Last updated: Apr 19, 2023

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~7 mo
High dilution risk
Lead asset
GammaCorePhase 2
Chronic Cluster Headache →